Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Matthews

Showing results (1211-1220 of 1,304) with videos related to

Pageof 131
Sort By:
Journal of the American Society of Nephrology : JASN|July 23, 2020
Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS ProgramMegumi Oshima, Bruce Neal, Tadashi Toyama, et al.
Biochemistry|May 19, 1987
Effect of single amino acid replacements on the folding and stability of dihydrofolate reductase from Escherichia coliK M Perry, J J Onuffer, N A Touchette, et al.
Diabetes, Obesity & Metabolism|January 26, 2017
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trialBruce Neal, Vlado Perkovic, David R Matthews, et al.
Journal of the American Society of Nephrology : JASN|September 19, 2019
Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
The Journal of Infectious Diseases|April 11, 1991
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infectionW L Drew, R C Miner, D F Busch, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 18, 2015
Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialGreg Fulcher, David R Matthews, Vlado Perkovic, et al.
Obesity Surgery|March 28, 2014
Why patients seek bariatric surgery: does insurance coverage matter?Phillip J Brantley, Krystal Waldo, Molly R Matthews-Ewald, et al.
Journal of Food Protection|May 5, 2019
Efficacy of a Low Concentration Iodine Postmilking Teat Disinfectant Against Contagious and Environmental Mastitis Pathogens in Two Dairy HerdsS P Oliver, M J Lewis, S H King, et al.
Journal of Nutrition and Metabolism|June 18, 2016
Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression on Activated B-Lymphocytes: A Plausible Mechanism for Downregulation of Acute Inflammatory ConditionsOmar K Danner, Leslie R Matthews, Sharon Francis, et al.
Alzheimer'S Research & Therapy|August 11, 2017
On the path to 2025: understanding the Alzheimer's disease continuumPaul S Aisen, Jeffrey Cummings, Clifford R Jack, et al.
Pageof 131

Showing results (1211-1220 of 1,304) with videos related to

Sort By:
Pageof 131
Journal of the American Society of Nephrology : JASN|July 23, 2020
Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS ProgramMegumi Oshima, Bruce Neal, Tadashi Toyama, et al.
Biochemistry|May 19, 1987
Effect of single amino acid replacements on the folding and stability of dihydrofolate reductase from Escherichia coliK M Perry, J J Onuffer, N A Touchette, et al.
Diabetes, Obesity & Metabolism|January 26, 2017
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trialBruce Neal, Vlado Perkovic, David R Matthews, et al.
Journal of the American Society of Nephrology : JASN|September 19, 2019
Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
The Journal of Infectious Diseases|April 11, 1991
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infectionW L Drew, R C Miner, D F Busch, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 18, 2015
Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialGreg Fulcher, David R Matthews, Vlado Perkovic, et al.
Obesity Surgery|March 28, 2014
Why patients seek bariatric surgery: does insurance coverage matter?Phillip J Brantley, Krystal Waldo, Molly R Matthews-Ewald, et al.
Journal of Food Protection|May 5, 2019
Efficacy of a Low Concentration Iodine Postmilking Teat Disinfectant Against Contagious and Environmental Mastitis Pathogens in Two Dairy HerdsS P Oliver, M J Lewis, S H King, et al.
Journal of Nutrition and Metabolism|June 18, 2016
Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression on Activated B-Lymphocytes: A Plausible Mechanism for Downregulation of Acute Inflammatory ConditionsOmar K Danner, Leslie R Matthews, Sharon Francis, et al.
Alzheimer'S Research & Therapy|August 11, 2017
On the path to 2025: understanding the Alzheimer's disease continuumPaul S Aisen, Jeffrey Cummings, Clifford R Jack, et al.
Pageof 131